The basis of the research was the analysis of the results of treatment of 130 patients with malignant fibrous histiocytoma of limbs soft tissues. The patients were treated at the National Cancer Institute from 1985 to 2016. The analysis made showed that the overall survival rate of the patients under examination depends on the location of the primary tumor. Indicators of recurrence-free survival differ significantly depending on the localization of the tumor. In relapsing patients overall survival is different and depends on the method of treatment. In the course of the first six years, the indicators of overall survival are better in the patients underwent only surgical treatment. The overall survival rate for all patients with MFH depends on the treatment method.

malignant fibrous histiocytoma of soft tissues; general survival; recurrent-free survival; surgical; combined; and complex treatment

Aliev MD (2004) Modern approaches to the treatment of soft tissue sarcomas. Practical Oncology, 5 (4): 250-255.

Shapiro NA., Patoroev YuK., Kislitsina LYu. (2009) Cytological diagnosis of soft tissue tumors. Atlas. - M. - Irkutsk, 5: 216.

Sekhina OV, Fedyanin M.Yu., Yakovleva E.S., Bulanov AA, Bokhyan B.Yu. (2011) Malignant fibrous histiocytomas. The results of the combined treatment of resectable forms. Sarcomas of bones, soft tissues and skin tumors, 4: 37-40.

Bolgova LS., Alekseenko OI., Loginova EA., Krotevich MS. (2014). Features of differential cytological diagnosis of malignant fibrous histiocytoma. Oncology.16 (3): 177-180.

Pobirci D.D., Bogdan F, Pobirci О.,et. al. (2011). Study of malignant fibrous histiocytoma: clinical, statistic and histopatological interrelation. Rom. J. Morphol. Embryol, 52(1 Suppl): 385-388.

Mankin HJ., Hornicek FJ., Delaney TF. [et.al.] (2012). Pleomorphic spindle cell sarcoma (PSCS) formerly known as malignant fibrous histiocytoma (MFH); a complex malignant soft-tissue tumor. Musculoskelet. Surg. 96(3): 171-177.

Milov VE. (2005). Treatment of patients with malignant fibrous histiocytoma (ZFG) of soft tissues and prognostic factors. Author's abstract dis. Cand. honey. sciences. - M., 22 p.

Aliev MD, Bohyan B.Yu., Burov D.A. (2013). The prognostic role of the resection margin in surgery of soft tissue sarcomas. Pract. Oncol 14: 97-100.

Pezzi CM., Rawlings MS., Esgro JJ., Pollock RE., Romsdahl MM. (1992). Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer. 69(8): 2098-2103.

Fagundes HM., Lai PP., Detainer LP., Perez CA., Garcia DM., Emami BF., Simpson JR., Kraybill WG., Kucik NA. (1992) Postoperative radiotherapy for malignant fibrous histiocytoma. Int. J. Radiat. Oncol. Biol. Phys. – 23(3): 615-619.

Belal A., Kandil A., Allam A. et. al. (2002) Malignant fibrous histiocytoma; a retrospective study of 109 cases. Am. J. clin. Oncol, 25(1): 16-22.

Chitturi RT., Nirmal RM., Sunil P M. et al. (2014). Evaluation of ploidy status using DNA-image cytometry of exfoliated mucosal cells in oral lichen planus. J. Cytol. 31 (3): 131-135.

Sekhina OV., Fedyanin MYu., Yakovleva ES., Bulanov AA., Bokhyan B Yu. (2011) Malignant fibrous histiocytomas. Results of the combined treatment of resectable sarcoma of bones, soft tissues and skin tumors, 4: 37-40.

Korovin SI, Ivankova VS., Ostafiychuk VV., Palivetz AYu., Kukushkina MM., Kostiuk VYu., Krotevich MS., Paliy MI. (2016) Immediate results of neoadjuvant therapy in patients with high risk sarcoma of soft tissues. Clinical Oncology, 1 (21): 16-18.

Cormier JN., Pollock RE. (2004). Soft tissue sarcomas. J. Clin. Oncol, 54(2): 94-109.

Ferguson PC. (2005). Surgical considerations for management of distal extremity soft tissue sarcomas. Curr. Opin. Oncol.,17: 366-369.

Eilber FC., Dry SM. (2008) Diagnosis and management of synovial sarcoma. J. Surg. Oncol., 97: 314-320.

Weitz J., Antonescu CR., Brennan MF. (2003) Localized extremity soft tissue sarcoma improved knowledge with unchanged survival over time. J. Clin. Oncol., 21: 2719-2725.

Aliyev, MD, Mehdiyeva, NI, Bokhyan, B. Yu. (2005). Factors of prognosis of soft tissue sarcomas. Questions of Oncology, 51 (3): 288-291.

Korovin SI, Ivankova VS, Ostafiychuk V.V., Palivets A.Yu., Kukushkina M. M., Paliy M.I. (2015). Combined treatment for patients with sarcoma of soft tissues of the limbs and trunk. Clinical Oncology, 3 (19): 32-35.

Koea JB., Leung D., Lewis J., et al. (2003). Histopathologic type: An independent prognostic factor in primary soft tissue sarcoma of the extremity. Ann. Surg. Oncol., 10 (4): 432 - 440.